COMPANION SCIENCES, INC.

Biotech · Private

Novel synthetic peptide therapeutic for treating anemia in companion animals (cats and dogs with chronic kidney disease)

Grants
$150K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Treatment for anemia in companion animals$150,000
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1111EPPIN PHARMA, INC.——
1112DiaMedica Therapeutics Inc.—$110M
1113JUN INNOVATIONS INC——
1114COMPANION SCIENCES, INC.——
1115Mu Therapeutics Inc.——
1116OPERATIONAL TECHNOLOGIES CORPORATION——
1117NUTRASORB LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.